IAVI, CureVac team up to accelerate AIDS vaccine development; GeoVax Ebola jab reports 100% protection in animal study;

> The International AIDS Vaccine Initiative (IAVI) is partnering with CureVac to accelerate the development of AIDS vaccines. Release

> GeoVax's Ebola vaccine posts 100% protection in guinea pigs and Syrian golden hamsters. More

> Walvax Biotechnology is using Medidata's ($MDSO) cloud-based platform to advance the development of a pediatric pneumococcal vaccine in China. Release

> Researchers at VIB and Ghent University in Belgium found a link between exposure to "farm dust" and protection against asthma and allergies. Release

Suggested Articles

Daiichi Sankyo says it still unable to fulfill a government mandate to be able to produce enough H5N1 flu vaccine to fight an epidemic in Japan.

GSK’s Shingrix has continuously impressed industry watchers with its growth, and the company just added another large market to its list: China.

WuXi Biologics says it will build a dedicated facility to manufacture a commercial vaccine product for a client in a $3 billion contract.